GlassScriptPhysician profile
Christopher D Hong
NPI 1730234626
$33,830.93
in general payments reported to CMS, 2019-2025
18 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $53.12 · 2021: $39.12 · 2022: $53.64 · 2023: $139 · 2024: $14K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,135.00 |
| Food and Beverage | $350.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $33,135.00 | 2024-2025 | Wainua, Imfinzi, Calquence |
| E.R. Squibb & Sons, L.L.C. | $113.56 | 2019-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $72.89 | 2019-2024 | |
| Pfizer INC. | $71.32 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $70.06 | 2022-2023 | Verquvo, Bridion |
| Astrazeneca Pharmaceuticals LP | $68.47 | 2019-2025 | Wainua |
| Amgen INC. | $58.83 | 2019-2025 | Repatha, Repatha |
| Lantheus Medical Imaging, INC. | $43.88 | 2019-2022 | |
| Philips North America LLC | $30.78 | 2025 | Event |
| Esperion Therapeutics, INC. | $29.64 | 2024 | Nexletol |
| Abbott Laboratories | $23.49 | 2021 | |
| Medtronic USA, INC. | $22.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.20 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.59 | 2019 | |
| Boston Scientific Corporation | $15.80 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.63 | 2021 | |
| Bridgebio Pharma, INC. | $15.48 | 2025 | Attruby |
| Altathera Pharmaceuticals LLC | $8.80 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.